HAEMONETICS CORP's ticker is HAE and the CUSIP is 405024100. A total of 296 filers reported holding HAEMONETICS CORP in Q2 2023. The put-call ratio across all filers is 0.26 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $2,225 | +115.2% | 24,837 | +104.5% | 0.10% | +133.3% |
Q2 2023 | $1,034 | -67.0% | 12,147 | -67.9% | 0.04% | -69.6% |
Q1 2023 | $3,134 | -99.6% | 37,879 | +228.7% | 0.15% | +184.6% |
Q3 2022 | $853,000 | -3.7% | 11,524 | -15.2% | 0.05% | -22.4% |
Q2 2022 | $886,000 | -3.4% | 13,587 | -6.3% | 0.07% | +11.7% |
Q1 2022 | $917,000 | +25.1% | 14,497 | +4.8% | 0.06% | -34.8% |
Q4 2021 | $733,000 | -14.4% | 13,829 | +14.0% | 0.09% | -19.3% |
Q3 2021 | $856,000 | – | 12,129 | – | 0.11% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Iron Triangle Partners LP | 330,000 | $36,633,000 | 4.66% |
BEACONLIGHT CAPITAL, LLC | 156,395 | $17,361,000 | 2.80% |
Bridge City Capital, LLC | 48,011 | $5,330,000 | 1.77% |
Summit Creek Advisors LLC | 121,362 | $13,472,000 | 1.61% |
Sivik Global Healthcare LLC | 25,000 | $2,775,000 | 1.01% |
ANCHOR CAPITAL ADVISORS LLC | 412,218 | $45,760,000 | 0.97% |
MESIROW FINANCIAL INVESTMENT MANAGEMENT - Fixed Income | 69,655 | $7,732,000 | 0.90% |
Orbimed Advisors | 852,000 | $94,581,000 | 0.88% |
LONDON CO OF VIRGINIA | 1,057,738 | $117,420,000 | 0.67% |
WEXFORD CAPITAL LP | 40,138 | $4,456,000 | 0.66% |